Ikarian Capital’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Hold |
619,258
| – | – | 0.23% | 52 |
|
|
2025
Q1 | $1.09M | Buy |
619,258
+535,851
| +642% | +$943K | 0.13% | 60 |
|
|
2024
Q4 | $222K | Buy |
83,407
+125
| +0.2% | +$333 | 0.03% | 103 |
|
|
2024
Q3 | $191K | Sell |
83,282
-275,000
| -77% | -$630K | 0.03% | 90 |
|
|
2024
Q2 | $1.05M | Sell |
358,282
-275,000
| -43% | -$803K | 0.18% | 51 |
|
|
2024
Q1 | $2.31M | Sell |
633,282
-589,570
| -48% | -$2.15M | 0.25% | 40 |
|
|
2023
Q4 | $1.85M | Hold |
1,222,852
| – | – | 0.17% | 40 |
|
|
2023
Q3 | $1.64M | Buy |
+1,222,852
| New | +$1.64M | 0.2% | 34 |
|
|
2022
Q2 | – | Sell |
-213,310
| Closed | -$1.12M | – | 139 |
|
|
2022
Q1 | $1.12M | Buy |
213,310
+13,310
| +7% | +$70K | 0.15% | 63 |
|
|
2021
Q4 | $1.7M | Buy |
+200,000
| New | +$1.7M | 0.25% | 47 |
|
|
2021
Q2 | – | Sell |
-250,000
| Closed | -$2.61M | – | 202 |
|
|
2021
Q1 | $2.61M | Buy |
250,000
+48,192
| +24% | +$504K | 0.09% | 88 |
|
|
2020
Q4 | $2.36M | Buy |
+201,808
| New | +$2.36M | 0.1% | 66 |
|